This inventor holds 1 USPTO granted patent. Top assignee: Toray Industries, Inc.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Nobuko Katayama: Innovator in Tumor Treatment
Introduction: Nobuko Katayama, a notable inventor based in Tokyo, Japan, has made significant contributions to medical technology with his innovative approach to treating malignant tumors. Holding one patent, his work reflects a deep commitment to advancing healthcare solutions for patients suffering from cancer.
Latest Patents: Nobuko Katayama's patent focuses on a novel method of treating malignant tumors. The method involves using lipopolysaccharides derived from the cell walls of Gram-negative bacteria, commonly known as endotoxins or pyrogens. In this innovative approach, these substances are immobilized on a solid, insoluble carrier. The blood, blood plasma, or blood serum of a tumor-bearing patient is then passed over the immobilized lipopolysaccharide-containing treatment material, providing a new avenue for tumor therapy.
Career Highlights: Katayama's career has been marked by significant achievements in the field of medical technology. He is affiliated with Toray Industries, Inc., a company known for its advancements in various technology sectors, including healthcare. His dedication to research and innovation has contributed to the development of effective methods in cancer treatment.
Collaborations: Throughout his career, Nobuko Katayama has collaborated with notable individuals such as Masashi Kodama and Yutaka Katayama, the latter of whom is remembered as a significant figure in his professional journey. These collaborations have likely fostered a creative environment that has led to impactful innovations in healthcare.
Conclusion: Nobuko Katayama stands out as a dedicated inventor whose work in tumor treatment represents hope for many patients. His patented methods highlight the intersection of technology and healthcare and illustrate the vital role of innovation in improving medical outcomes. Through continued research and collaboration, Katayama and his peers are paving the way for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
